Table 3.
Important regulatory genes and pathways related to lipid metabolism in comparison of control group and BS15 group
| Pathway | P-value | Pathway ID | Genes |
|---|---|---|---|
| Steroid biosynthesis | 7.64E-09 | gga00100 | CYP51A1; DHCR7; LIPA; MSMO1; SQLE |
| Fatty acid metabolism | 0.00093 | gga01212 | ACSBG1; HADHA; SCD5 |
| Fatty acid elongation | 0.00113 | gga00062 | ELOVL1; HADHA |
| Biosynthesis of unsaturated fatty acids | 0.00131 | gga01040 | HADHA; SCD5 |
| PPAR signaling pathway | 0.00332 | gga03320 | ACSBG1; FABP2; SCD5 |
| Steroid hormone biosynthesis | 0.00374 | gga00140 | CYP17A1; CYP1B1 |
| Fatty acid degradation | 0.00450 | gga00071 | ACSBG1; HADHA |
| Fatty acid biosynthesis | 0.00801 | gga00061 | ACSBG1 |
| Adipocytokine signaling pathway | 0.02749 | gga04920 | ACSBG1; SOCS3 |
| Butanoate metabolism | 0.02841 | gga00650 | HADHA |
| beta-Alanine metabolism | 0.03058 | gga00410 | HADHA |
| Ether lipid metabolism | 0.05823 | gga00565 | LPCAT1 |
| Glycerophospholipid metabolism | 0.22438 | gga00564 | LPCAT1 |
| Insulin resistance | 0.27196 | gga04931 | SOCS3 |
| Insulin signaling pathway | 0.35875 | gga04910 | SOCS3 |